344 related articles for article (PubMed ID: 30347414)
1. Harms and Benefits of Using Aspirin for Primary Prevention of Cardiovascular Disease: A Narrative Overview.
Lippi G; Danese E; Favaloro EJ
Semin Thromb Hemost; 2019 Mar; 45(2):157-163. PubMed ID: 30347414
[TBL] [Abstract][Full Text] [Related]
2. The role of aspirin as antiaggregant therapy in primary prevention. An update.
Jiménez-García N; de la Torre Lima J; García Alegría J
Med Clin (Barc); 2019 Oct; 153(8):326-331. PubMed ID: 31521369
[TBL] [Abstract][Full Text] [Related]
3. The aspirin controversy in primary prevention.
Raju NC; Eikelboom JW
Curr Opin Cardiol; 2012 Sep; 27(5):499-507. PubMed ID: 22874127
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variation in PEAR1, Cardiovascular Outcomes and Effects of Aspirin in a Healthy Elderly Population.
Lewis JP; Riaz M; Xie S; Polekhina G; Wolfe R; Nelson M; Tonkin AM; Reid CM; Murray AM; McNeil JJ; Shuldiner AR; Lacaze P
Clin Pharmacol Ther; 2020 Dec; 108(6):1289-1298. PubMed ID: 32562573
[TBL] [Abstract][Full Text] [Related]
5. Aspirin use for primary prevention in elderly patients.
Terrosu P
Monaldi Arch Chest Dis; 2016 Jun; 84(1-2):728. PubMed ID: 27374042
[TBL] [Abstract][Full Text] [Related]
6. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force.
Wolff T; Miller T; Ko S
Ann Intern Med; 2009 Mar; 150(6):405-10. PubMed ID: 19293073
[TBL] [Abstract][Full Text] [Related]
7. Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials.
Kunutsor SK; Seidu S; Khunti K
Diabet Med; 2017 Mar; 34(3):316-327. PubMed ID: 27086572
[TBL] [Abstract][Full Text] [Related]
8. An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.
Kolber MR; Korownyk C
Expert Opin Pharmacother; 2014 Feb; 15(2):153-7. PubMed ID: 24206142
[TBL] [Abstract][Full Text] [Related]
9. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL
JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466
[TBL] [Abstract][Full Text] [Related]
10. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
Stavrakis S; Stoner JA; Azar M; Wayangankar S; Thadani U
Am J Med Sci; 2011 Jan; 341(1):1-9. PubMed ID: 21191260
[TBL] [Abstract][Full Text] [Related]
11. Clinical Inquiries: What are the benefits and risks of daily low-dose aspirin for primary prevention of CV events?
Mutter J; Grandy R; Hulkower S; Stigleman S
J Fam Pract; 2018 Apr; 67(4):247-248. PubMed ID: 29614147
[TBL] [Abstract][Full Text] [Related]
12. Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE).
Nelson M; Reid C; Beilin L; Donnan G; Johnston C; Krum H; Storey E; Tonkin A; McNeil J;
Drugs Aging; 2003; 20(12):897-903. PubMed ID: 14565783
[TBL] [Abstract][Full Text] [Related]
13. Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit-Harm Analysis.
Selak V; Jackson R; Poppe K; Wu B; Harwood M; Grey C; Pylypchuk R; Mehta S; Choi YH; Kerr A; Wells S
Ann Intern Med; 2019 Oct; 171(8):529-539. PubMed ID: 31525775
[TBL] [Abstract][Full Text] [Related]
14. Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis.
Zheng SL; Roddick AJ
JAMA; 2019 Jan; 321(3):277-287. PubMed ID: 30667501
[TBL] [Abstract][Full Text] [Related]
15. Aspirin and cardiovascular primary prevention in non-endstage chronic kidney disease: A meta-analysis.
Major RW; Oozeerally I; Dawson S; Riddleston H; Gray LJ; Brunskill NJ
Atherosclerosis; 2016 Aug; 251():177-182. PubMed ID: 27341534
[TBL] [Abstract][Full Text] [Related]
16. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
17. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
McNeil JJ; Wolfe R; Woods RL; Tonkin AM; Donnan GA; Nelson MR; Reid CM; Lockery JE; Kirpach B; Storey E; Shah RC; Williamson JD; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Orchard SG; Trevaks RE; Beilin LJ; Johnston CI; Ryan J; Radziszewska B; Jelinek M; Malik M; Eaton CB; Brauer D; Cloud G; Wood EM; Mahady SE; Satterfield S; Grimm R; Murray AM;
N Engl J Med; 2018 Oct; 379(16):1509-1518. PubMed ID: 30221597
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
[TBL] [Abstract][Full Text] [Related]
19. [Primary prevention of cardiovascular diseases with acetylsalicylic acid].
Waltering A; Hemkens L; Florack C
Dtsch Med Wochenschr; 2005 Dec; 130(49):2847-52. PubMed ID: 16317615
[TBL] [Abstract][Full Text] [Related]
20. Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials.
Barbarawi M; Kheiri B; Zayed Y; Gakhal I; Al-Abdouh A; Barbarawi O; Rashdan L; Rizk F; Bachuwa G; Alkotob ML
High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):283-291. PubMed ID: 31280451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
